Abstract Sudden unexplained nocturnal death syndrome (SUNDS) is a perplexing disorder to both forensic pathologists and clinic physicians. Desmoplakin (DSP) gene was the first desmosomal gene linked to arrhythmogenic right ventricular cardiomyopathy (ARVC) which was associated with sudden death. To identify the genetic variants of the DSP gene in SUNDS in the southern Chinese Han population, we genetically screened the DSP gene in 40 sporadic SUNDS victims, 16 Brugada syndrome (BrS) patients, and 2 early repolarization syndrome (ERS) patients using next generation sequencing (NSG) and direct Sanger sequencing. A total of 10 genetic
Introduction
Sudden unexplained nocturnal death syndrome (SUNDS) is a perplexing disorder often presenting to forensic pathologists [1] [2] [3] . SUNDS prevails in Southeast Asia and has some common clinical features: (1) the majority of the decedents are male, apparently healthy, 20 to 50 years old; (2) the death mostly occurred at night during sleep or at rest; (3) no evident histopathology changes explain the cause of death. Lethal cardiac arrhythmias were assumed to be associated with the pathogenesis of sudden cardiac death (SCD) in the young, such as congenital long QT syndrome (LQTS), Brugada syndrome (BrS), catecholaminergic polymorphic ventricular tachycardia (CPVT), and arrhythmogenic right ventricular cardiomyopathy (ARVC) [4] .
Desmosomes are intercellular junctions that tightly link adjacent cells. Desmoplakin (DSP) is essential for normal desmosomal adhesion; it links the desmosomes and intermediate filaments to maintain mechanical integrity of cardiomyocytes [5] . DSP was the first desmosomal gene linked to autosomal dominant ARVC [6] . Almost 100 DSP pathogenic variants have been related to ARVC (type 8) with 40 % missense variants, 30 % nonsense variants, and the rest being small insertion/deletions or changes that alter splicing sites [7] . Current studies showed that the misregulation of DSP affected the expression and redistribution of Cx43, concomitant with the expression of Nav1.5 [8] . We hypothesized that both DSP mutantassociated ARVC and DSP-mediated abnormality of Nav1.5 may contribute to the pathogenesis of some SUNDS cases.
We have performed postmortem molecular autopsy in sporadic cases of SUNDS on the lethal cardiac arrhythmia-associated genes (SCN5A, SCN1B-4B, GPD1L, MOG1, KCNQ1, KCNH2, KCNE1, KCNE2, and RyR2) in the southern Chinese Han population and found that inherited cardiac arrhythmias, such as LQTS, BrS, CPVT, and ARVC may explain the cause of death in just under 20 % of SUNDS [1] [2] [3] , leaving unclear the genetic etiology of more than 80 % of SUNDS. With the goal of identifying additional genes associated with SUNDS, in this study, we screened our SUNDS cohort for variants in the DSP gene.
Materials and methods

Study population
We screened 40 sporadic SUNDS cases referred to the Department of Forensic Pathology, Zhongshan School of Medicine, Sun Yat-sen University, from 2005 to 2014, as defined by the following inclusion criteria [9] : (1) southern Chinese Han male, older than or equal to 18 years old, (2) in good antemortem health without any significant disease relating to the death, (3) sudden unexpected death during sleep or rest, and (4) a negative comprehensive forensic autopsy. In addition to SUNDS cases, 16 patients with BrS and 2 patients with early repolarization syndrome (ERS) were also screened in this study. Genetic screening controls were collected from 110 unrelated apparently healthy males in southern China, provided by the First Affiliated Hospital of Sun Yat-sen University. All participants gave informed consent and the principles outlined in the Declaration of Helsinki were followed. The project was approved for human research by the ethics committee of Sun Yat-sen University.
Genetic variants analysis
The genomics DNA was extracted from the dried blood spot using the Magen Bind Blood and Tissue kit (Magen, Guangzhou, China) and was quantified with Qubit® 2.0 Fluorometer (Qubit® dsDNA HS Assay Kit). Library preparation was performed by the standard Illumina protocols [10] and then the prepared library was hybridized to the customized probe following standard SureSelect QXT Target Enrichment for Illumina Multiplexed Sequencing protocol (Agilent, USA). At last, the final captured DNA libraries were sequenced using the Illumina HiSeq2500 Analyzers. Image analysis and base calling were performed using the Illumine pipeline. After the entire run was completed, primary reads were generated. The average depth of the target regions of all samples is over 200×, and over 98 % of the bases were covered >50×. Variants with a depth of coverage <30× or a heterozygous reads ratio <20 % was excluded.
Unqualified reads were filtered out using the SOAPnuke software (http://soap.genomics.org.cn/) developed by BGI. Aligned the resulting reads to the hg19 reference genome with BWA version 0.7.10-r789 [11] , marked duplications by Picard tools (http://picard. sourceforge.net), applied GATK [12] base quality score recalibration, indel realignment, duplicate removal, and performed SNP and INDEL discovery and genotyping across all samples simultaneously using standard hard filtering parameters or variant quality score recalibration according to GATK Best Practices recommendations [13, 14] . Finally, variant calls were annotated with NCBI database (Build 37).
A total of 80 genes associated with inherited cardiac arrhythmia (Table 1) were investigated using target captured next generation sequencing technology.
All the variants were filtered for candidate mutations based on the following: allele frequency in 1000G database, the functional mutation types, the predictive programs (SIFT, Polyphen2, and CONDEL software), and related published literature. Briefly, allele frequency above 1 % was considered to be a sequence polymorphisms and nonsense, frameshift, splice-site mutations were considered to be candidate pathogenic mutations unless identified as a polymorphism. All the filtered variants were then classified to five categories based on their clinical significance (pathogenic, likely pathogenic, uncertain, likely benign, and benign) according the ACMG Guidelines Revisions 2007 [15] .
All the pathogenic and likely pathogenic mutation and some rare genetic variants in DSP gene were confirmed by Sanger direct sequencing (the primer sequences and PCR conditions are in the table in Electronic Supplementary Material on line). The sequencing data were compared with the corresponding reference cDNA sequence of DSP gene (NM_004415.2) using SeqMan ™ II sequence analysis software (DNASTAR, Inc., Madison, WI, USA). These detected variants were also screened in 110 unrelated ethnically matched healthy controls.
Results
The investigation of the 80 candidate genes in both SUNDS victims and clinical patients yielded rich novel or reported mutations, rare variants, and polymorphisms. The additional cases, and the detailed epidemiological, morphological, and clinical data are being accumulated to address the molecular pathological spectrum of Chinese SUNDS for the first time.
Considering the independent role of DSP gene in SUNDS and the uncertain delay time of the whole study, we just aimed to report the new findings of DSP gene screening in SUNDS in this paper. Among the total 58 cases, 10 DSP gene missense variants were identified in 11 cases (Fig 1 and Table 2 ); these variants were all absent in 110 healthy controls. Of the 10 variants, 7 were identified in SUNDS, 2 were identified in BrS, and 1 in ERS. In these 11 cases with DSP variants, there were no reported pathogenic mutations detected in known LQTS, BrS, SQTS, CPVT, and ARVC-associated genes (Table 1 ). There were common polymorphisms found in these 11 cases in the screened 80 genes (which will be reported separately). Eight of these 10 variants were previously catalogued in international databases (NCBI and database of BGI) and 2 were novel (p.I125F and p.D521A). Of eight reported variants, two were previously considered pathogenic (p.Q90R and p.R2639Q), three were predicted in silico as pathogenic (p.R315C, p.E1357D, and p.D2579H), and three were predicted as benign (p.N1234S, p.R1308Q, and p.T2267S).
One of the two pathogenic mutations, p.Q90R (rs188516326), is located in exon 5 of the DSP gene in SUNDS case E128. The substitution c.269A>G leads to a replacement of glutamine by arginine. The minimum allele frequency (MAF) was 0.01/0.005 (Han Chinese in Beijing/ Southern Han Chinese, respectively, data from 1000 Genomes Project). The other variant p.R2639Q (rs116888866) is located in exon 24 of the DSP gene in SUNDS case E101 and SUNDS case A7600. The substitution c.7916G>A leads to a replacement of arginine by glutamine. The MAF was 0.015/ 0.019 (Han Chinese in Beijing/Southern Han Chinese, respectively, data from 1000 Genomes Project).
Six more variants were reported previously in public databases but with unknown disease effect. The first three were p.N1234S (rs185367490), p.R1308Q (rs185367490), and p.E1357D (rs569786610), the three variants all located in exon 23 with c.3701A>G, c.3923G>A, and c.4071G>C substitution, respectively. The variants p.N1234S and p.R1308Q were predicted in silico to be benign and p.E1357D was predicted to be malignant.
T h e o t h e r t h r e e D S P v a r i a n t s w e r e p . R 3 1 5 C (rs200476515), p.T2267S (rs181378432), and p.D2579H. The p.R315C variant has a nucleotide change of C-T in the position 943 and is located in exon 8. The p.T2267S and p.D2579H variant had nucleotide changes of A-T in the position 6679 and G-C in the position of 7735, respectively, both located in exon 24. The variants p.R315C and p. D2579H were predicted to be malignant and p.T2267S was predicted to be benign. Interestingly, p.R315C (rs200476515) was novel in database of BGI while p.D2579H with MAF 0.0004 in the database of BGI was absent in dbSNP, neither was considered to be novel in this study. Finally, two novel variants p.I125F and p.D521A were located in exon 3 and exon 12, respectively. The variant p.I125F has an A-T nucleotide change in the position 373 and was predicted in silico to be malignant. The variant p.D521A has an A-C nucleotide change in the position of 1562 and was predicted to be benign.
Discussion
In this study, we focused our genetic analysis on the DSP gene coding desmoplakin in the desmosome. Desmosomes are transmembrane multiprotein complexes that provide important intercellular structural integrity. Desmoplakin is a component of desmosome that acts as an intracellular link between other desmosomal components and intermediate filaments [16] . Mutations in desmosomal components including DSP are associated with arrhythmogenic cardiomyopathy (AC) [17, 18] , an inherited disorder that comprises both an arrhythmia component and structural features.
In case E101 and A7600, a rare SNP c.7916G>A at codon 2639 in exon 24 of DSP was identified, leading to replacement of arginine with glutamine (R2639Q). Yu et al. [19] reported the same mutation in a patient who did not at the time meet the diagnostic criteria for ARVC but had sustained ventricular tachycardia on an ECG with the patient experiencing palpitations. They concluded that the patient was very likely to have ARVC because of severe dilatation and dysfunction of the right ventricle revealed by the subsequent cardiac MRI. Sato et al. also reported the same mutation in a sudden death case, the decedent, an 18-year-old man with no previous medical history, died suddenly during a class at school [20] .
The Q90R variation has been identified in previous studies [21] [22] [23] . Yang et al. found the N-terminal missense mutation of DSP Q90R affected the normal localization of DSP to cell membranes in vitro, probably, due to loss of binding to the desmosomal protein JUP. In addition, overexpression of the Q90R mutant in embryonic mouse heart leads to embryonic lethality [21] . At autopsy, no histopathologic features of AC were detected in our SUNDS cases. In the early stage of AC, sudden cardiac death can occur due to ventricular fibrillation, even in the absence of overt structural defect. This early concealed phase of AC is characterized by a propensity to ventricular arrhythmia and SCD in the setting of well-preserved morphology, histology, and ventricular function [16] . Previous findings suggest that Cx43 reduction associated with electrophysiological abnormalities may appear prior to fibrosis in the myocardium of AC patients with DSP gene mutations [24] , consistent with the finding in the cardiomyocytes from mice with knockout of DSP (DSP-cKO) [25] . These findings suggest that the histopathology changes are not necessary to generate arrhythmia, while less is known about the nature of the arrhythmogenic substrate during the concealed phase of ARVC [25] .
The desmosome is a specialized adhesive junction that participates in crosstalk with gap junctions. Mutations in components of the desmosome (including desmoplakin) underlie AC. The gap junction channel is composed of two connexons and each connexon consists of six connexins. Cx43 is the most abundant connexin isotype in heart. If gap junction channels are not present, normal propagation is disrupted and lethal arrhythmias ensue [26, 27] . Lyon et al. found that in the DSPcKO mice, the gap junction at the intercalated disks in cardiac ventricular cells is lost with the loss of desmoplakin and dosedependent loss of desmoplakin directly affects the expression and phosphorylation of Cx43 [25] . Zhang et al. effectively demonstrate that loss of DSP gene leads to the downexpression and redistribution of the Nav1.5 protein, and decreased DSP expression results in the decrease of sodium current as well as the slower of conduction velocity in cultured DSP-depleted HL-1 cells [8] . Further, Patel et al. showed that DSP regulates the EB1-based targeted delivery of Cx43 to the membrane, and that this delivery does not occur when DSP gene mutants exist in the N terminus hotspot [28] . Jansen showed in inducible Cx43 knockout mice with arrhythmia, the heterogeneous expression of Cx43 was concomitant with heterogeneous expression of Nav1.5, and patch-clamp experiments in isolated adult rat ventricular myocytes showed that the loss of Cx43 expression led to a significant reduction in the sodium current amplitude [29] . These studies suggest that the loss of DSP brings out the heterogeneous and combined misregulation of Cx43 and Nav1.5, and lead to slowed and dispersed conduction, which sensitizes the heart for ventricular arrhythmia.
Although the functional effects of the mutations we report here are not yet known, these known effects of loss of DSP function suggest the plausibility or pathogenicity for the clinical syndrome of SUNDS and BrS. Additional data supporting the possible pathogenicity of these mutations include their absence from healthy controls and very low frequency in online databases, and some of them have been found to be pathogenic previously. For our forensic investigations, meticulous gross autopsy and pathological detection was important to establish the cohort of negative autopsy cases. However, the absence of clinical data and family history often made it difficult to determine the cause of death. Postmortem genetic analysis can be a powerful technique [30, 31] that combined with the traditional forensic investigation may contribute to finding the underlying causes for SUNDS.
Conclusion
In summary, we identified 10 DSP gene variants in 11 cases (8 SUNDS victims, 2 BrS patients, and 1 ERS patient) out of 70 postmortem or clinical cases. No known pathogenic mutation or novel variants associated with LQTS, BrS, SQTS, and CPVT were detected in the 11 cases that might otherwise account for their clinical presentation. Considering the low frequency in population, the absence in control, the presence in sudden cardiac death, and the known regulation of DSP on Cx43 and Nav1.5, we deduced that the variants in DSP gene identified in this study are genetic causes of some SUNDS cases. Ongoing electrophysiological investigations may determine whether they affect function and confirm and support their role as pathogenic variants by establishing the biophysical mechanism by which they cause SUNDS and BrS.
